The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer
Open accessAbstract
Superparamagnetic iron oxide nanoparticles (SPION) have emerged as an MRI contrast agent for tumor imaging due to their efficacy and safety. Their utility has been proven in clinical applications with a series of marketed SPION-based contrast agents. Extensive research has been performed to study various strategies that could improve SPION by tailoring the surface chemistry and by applying additional therapeutic functionality. Research into the dual-modal contrast uses of SPION has developed because these applications can save time and effort by reducing the number of imaging sessions. In addition to multimodal strategies, efforts have been made to develop multifunctional nanoparticles that carry both diagnostic and therapeutic cargos specifically for cancer. This review provides an overview of recent advances in multimodality imaging agents and focuses on iron oxide based nanoparticles and their theranostic applications for cancer. Furthermore, we discuss the physiochemical properties and compare different synthesis methods of SPION for the development of multimodal contrast agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
Inorganic Nanoparticles for MRI Contrast Agents
Na, H. B., Song, I. C., & Hyeon, T. (2009) · Advanced Materials · doi:10.1002/adma.200802366 · Cited by 1,781
Multifunctional nanoparticles for multimodal imaging and theragnosis
Lee, D.-E., Koo, H., Sun, I.-C., Ryu, J. H., Kim, K., & Kwon, I. C. (2012) · Chem. Soc. Rev. · doi:10.1039/c2cs15261d · Cited by 1,410
Wang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles
Laurent, S., Dutz, S., Häfeli, U. O., & Mahmoudi, M. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2011.04.003 · Cited by 1,326
Molecular imaging in drug development
Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2290 · Cited by 1,171
Ntziachristos, V., Bremer, C., & Weissleder, R. (2003) · European Radiology · doi:10.1007/s00330-002-1524-x · Cited by 982
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Chemical Design of Nanoparticle Probes for High‐Performance Magnetic Resonance Imaging
Jun, Y., Lee, J., & Cheon, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200701674 · Cited by 839
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
Thorek, D. L. J., Chen, A. K., Czupryna, J., & Tsourkas, A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9002-7 · Cited by 772
Theranostic Magnetic Nanoparticles
Yoo, D., Lee, J.-H., Shin, T.-H., & Cheon, J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200085c · Cited by 730
Yu, M. K., Jeong, Y. Y., Park, J., Park, S., Kim, J. W., Min, J. J., Kim, K., & Jon, S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800857 · Cited by 615
Self-citationSuperparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Wáng, Y. X. J. (2011) · PubMed · doi:10.3978/j.issn.2223-4292.2011.08.03 · Cited by 613
Applications and potential toxicity of magnetic iron oxide nanoparticles
Liu, G., Gao, J., Ai, H., & Chen, X. (2013) · Small · doi:10.1002/smll.201201531 · Cited by 570 · cited 2×
“leading to apoptosis or cell death [21].”
BackgroundNanoplatforms for Targeted Molecular Imaging in Living Subjects
Cai, W., & Chen, X. (2007) · Small · doi:10.1002/smll.200700351 · Cited by 563
Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery
Dobson, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302720 · Cited by 562
Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis
Nahrendorf, M., Zhang, H., Hembrador, S., Panizzi, P., Sosnovik, D. E., Aikawa, E., Libby, P., Swirski, F. K., & Weissleder, R. (2008) · Circulation · doi:10.1161/circulationaha.107.741181 · Cited by 559
Lee, H.-Y., Li, Z., Chen, K., Hsu, A. R., Xu, C., Xie, J., Sun, S., & Chen, X. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051243 · Cited by 557
Chemical Design of Biocompatible Iron Oxide Nanoparticles for Medical Applications
Ling, D., & Hyeon, T. (2013) · Small · doi:10.1002/smll.201202111 · Cited by 493
PET/NIRF/MRI triple functional iron oxide nanoparticles
Xie, J., Chen, K., Huang, J., Lee, S., Wang, J., Gao, J., Li, X., & Chen, X. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.010 · Cited by 493
Targeted nanoparticles for cancer therapy
Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., Langer, R. S., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 478
Principles of CT and CT Technology
Goldman, L. W. (2007) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.107.042978 · Cited by 445
‘Two is better than one’—probes for dual-modality molecular imaging
Jennings, L. E., & Long, N. J. (2009) · Chemical Communications · doi:10.1039/b821903f · Cited by 438
Yang, X., Hong, H., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Xiao, Y., Yang, Y., Zhang, Y., Nickles, R. J., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.006 · Cited by 436
Targeted Nanoparticles for Cancer Therapy
Reddy, G. S. N. (2021) · Journal of Bioanalysis & Biomedicine · Cited by 401
Near-Infrared Fluorescent Nanoparticles as Combined MR/Optical Imaging Probes
Josephson, L., Kircher, M. F., Mahmood, U., Tang, Y., & Weissleder, R. (2002) · Bioconjugate Chemistry · doi:10.1021/bc015555d · Cited by 371
Lee, J., Lee, K., Moon, S. H., Lee, Y., Park, T. G., & Cheon, J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805998 · Cited by 365
Santra, S., Kaittanis, C., Grimm, J., & Perez, J. M. (2009) · Small · doi:10.1002/smll.200900389 · Cited by 353
Micellar Hybrid Nanoparticles for Simultaneous Magnetofluorescent Imaging and Drug Delivery
Park, J., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801810 · Cited by 333
Lee, H., Yu, M. K., Park, S., Moon, S., Min, J. J., Jeong, Y. Y., Kang, H.-W., & Jon, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072210i · Cited by 330
Self-citationIron oxide nanoparticles for targeted cancer imaging and diagnostics
Rosen, J. E., Chan, L., Shieh, D.-B., & Gu, F. X. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.017 · Cited by 329
Lee, G. Y., Qian, W. P., Wang, L., Wang, Y. A., Staley, C. A., Satpathy, M., Nie, S., Mao, H., & Yang, L. (2013) · ACS Nano · doi:10.1021/nn3043463 · Cited by 324
Gamarra, L., Silva, A. C., Oliveira, T. R., Mamani, J. B., Malheiros, S. M. F., Malavolta, L., Pavon, L. F., Sibov, T. T., Amaro Jr, E., & Gamarra, L. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s14737 · Cited by 294
Toxicity of MRI and CT contrast agents
Hasebroock, K. M., & Serkova, N. J. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902873796 · Cited by 242
Multimodality Imaging: Beyond PET/CT and SPECT/CT
Cherry, S. R. (2009) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.03.001 · Cited by 238
In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe
Moore, A., Medarova, Z., Potthast, A., & Dai, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3230 · Cited by 226
Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges
He, X., Gao, J., Gambhir, S. S., & Cheng, Z. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.006 · Cited by 223
HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy
Quan, Q., Xie, J., Gao, H., Yang, M., Zhang, F., Liu, G., Lin, X., Wang, A., Eden, H. S., Lee, S., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200006f · Cited by 223
Optical contrast agents and imaging systems for detection and diagnosis of cancer
Pierce, M. C., Javier, D. J., & Richards‐Kortum, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23858 · Cited by 204
99mTc-Bisphosphonate-Iron Oxide Nanoparticle Conjugates for Dual-Modality Biomedical Imaging
Torres Martin de Rosales, R., Tavaré, R., Glaria, A., Varma, G., Protti, A., & Blower, P. J. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100483k · Cited by 203
Molecular imaging perspectives
Cassidy, P. J., & Radda, G. K. (2005) · Journal of The Royal Society Interface · doi:10.1098/rsif.2005.0040 · Cited by 195
Torres Martin de Rosales, R., Tavaré, R., Paul, R. L., Jauregui‐Osoro, M., Protti, A., Glaria, A., Varma, G., Szanda, I., & Blower, P. J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007894 · Cited by 181
Magnetic Nanoparticle-Based Hyperthermia for Head & Neck Cancer in Mouse Models
Zhao, Q., Wang, L., Cheng, R., Mao, L., Arnold, R. D., Howerth, E. W., Chen, Z. G., & Platt, S. (2012) · Theranostics · doi:10.7150/thno.3854 · Cited by 165
Molecular optical imaging: Applications leading to the development of present day therapeutics
Shah, K., & Weissleder, R. (2005) · NeuroRX · doi:10.1602/neurorx.2.2.215 · Cited by 164
Molecular Magnetic Resonance Imaging in Cardiovascular Medicine
Sosnovik, D. E., Nahrendorf, M., & Weissleder, R. (2007) · Circulation · doi:10.1161/circulationaha.106.658930 · Cited by 157
Madru, R., Kjellman, P., Olsson, F., Wingårdh, K., Ingvar, C., Ståhlberg, F., Olsrud, J., Lätt, J., Fredriksson, S., Knutsson, L., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092437 · Cited by 154
Amphiphilic polymer-coated hybrid nanoparticles as CT/MRI dual contrast agents
Kim, D., Yu, M. K., Lee, T. S., Park, J. J., Jeong, Y. Y., & Jon, S. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/15/155101 · Cited by 150
Self-citationGd-doped iron-oxide nanoparticles for tumour therapy via magnetic field hyperthermia
Drake, P. L., Cho, H.-J., Shih, P.-S., Kao, C., Lee, K.-F., Kuo, C.-H., Lin, X., & Lin, Y.-J. (2007) · Journal of Materials Chemistry · doi:10.1039/b711962c · Cited by 149
Kumar, K., Nightingale, A. M., Krishnadasan, S. H., Kamaly, N., Arridge, M., Zeissler, K., Branford, W. R., Ware, E., deMello, A. J., & de Mello, J. C. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm30257h · Cited by 133
Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application
Hoskins, C., Min, Y., Gueorguieva, M. J., McDougall, C., Volovick, A., Prentice, P., Wang, Z., Melzer, A., Cuschieri, A., & Wang, L. (2012) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-10-27 · Cited by 128
Osborne, E. A., Atkins, T. M., Gilbert, D. A., Kauzlarich, S. M., Liu, K., & Louie, A. Y. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/21/215602 · Cited by 115
In vivo imaging of tumor response to therapy using a dual‐modality imaging strategy
Medarova, Z. O., Pham, W. N., Kim, Y. R., Dai, G., & Moore, A. V. (2005) · International Journal of Cancer · doi:10.1002/ijc.21672 · Cited by 110
Non‐invasive molecular imaging for preclinical cancer therapeutic development
O’Farrell, A. C., Shnyder, S. D., Marston, G., Coletta, P. L., & Gill, J. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12155 · Cited by 109
Dendronized iron oxide nanoparticles for multimodal imaging
Lamanna, G., Kueny‐Stotz, M., Mamlouk, H., Ghobril, C., Basly, B., Bertin, A., Miladi, I., Billotey, C., Pourroy, G., Bégin‐Colin, S., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.026 · Cited by 97
Zeng, L., Ren, W., Zheng, J., Cui, P., & Wu, A. (2011) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp23196d · Cited by 86
Targeted near-IR hybrid magnetic nanoparticles for in vivo cancer therapy and imaging
Kirui, D. K., Khalidov, I., Wang, Y., & Batt, C. A. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.009 · Cited by 76
Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe
Misri, R., Meier, D., Yung, A. C., Kozłowski, P., & Häfeli, U. O. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.10.013 · Cited by 73
Methods to monitor gene therapy with molecular imaging
Waerzeggers, Y., Monfared, P., Viel, T., Winkeler, A., Voges, J., & Jacobs, A. H. (2009) · Methods · doi:10.1016/j.ymeth.2009.03.007 · Cited by 67
Development of MRI/NIRF ‘activatable’ multimodal imaging probe based on iron oxide nanoparticles
Cha, E., Jang, E., Sun, I., Lee, I. J., Ko, J. H., Kim, Y., Kwon, I. C., Kim, K., & Ahn, C.-H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.019 · Cited by 61
Yoo, M. K., Kim, I. Y., Kim, E. M., Jeong, H., Lee, C., Jeong, Y. Y., Akaike, T., & Cho, C. S. (2007) · BioMed Research International · doi:10.1155/2007/94740 · Cited by 54
Self-citationBelaïd, S., Laurent, S., Vermeersch, M., Elst, L. V., Pérez-Morga, D. L., & Müller, R. N. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/5/055705 · Cited by 53
Agents that induce pseudo-allergic reaction
Wang, H. (2011) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2011.v5.5.211 · Cited by 49
Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer
Huang, K., Chen, Y., Wang, W., Lian, G., Qian, C., Wang, L., Zeng, L., Liao, C., Liang, B., Huang, B. Q., et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s24083 · Cited by 40
Multimodal iron oxide nanoparticles for hybrid biomedical imaging
Heidt, T., & Nahrendorf, M. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2872 · Cited by 36
Dey, S., & Maiti, T. K. (2012) · Journal of Nanomaterials · doi:10.1155/2012/129107 · Cited by 17
Cited by
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Magnetic Nanoparticles: Surface Effects and Properties Related to Biomedicine Applications
Issa, B., Obaidat, I., Albiss, B., & Haik, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121266 · Cited by 1,245
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
Kalyane, D., Raval, N., Maheshwari, R., Tambe, V., Kalia, K., & Tekade, R. K. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.01.066 · Cited by 849
Techniques for physicochemical characterization of nanomaterials
Lin, P.-C., Lin, S., Wang, P. C., & Sridhar, R. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.006 · Cited by 708
Metadata
- Authors
- Thomas, R., Park, I.-K., & Jeong, Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2013-07-31
- Volume
- 14
- Issue
- 8
- Pages
- 15910-15930
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2065283727
- Cited by
- 271
- References
- 66
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.